Literature DB >> 8793407

Mycobacterium fortuitum bacteremia in an immunocompromised patient with a long-term venous catheter.

A Moreno, M Llanos, A González, N Batista.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8793407     DOI： 10.1007/bf01690105

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  9 in total

1.  Fastidious mycobacteria grown from porcine prosthetic-heart-valve cultures.

Authors:  L F Laskowski; J J Marr; J F Spernoga; N J Frank; H B Barner; G Kaiser; D H Tyras
Journal:  N Engl J Med       Date:  1977-07-14       Impact factor: 91.245

2.  Disseminated Mycobacterium chelonei infection: a report of two cases.

Authors:  J C Pottage; A A Harris; G M Trenholme; S Levin; R L Kaplan; J M Feczko
Journal:  Am Rev Respir Dis       Date:  1982-10

3.  Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers.

Authors:  G Bolan; A L Reingold; L A Carson; V A Silcox; C L Woodley; P S Hayes; A W Hightower; L McFarland; J W Brown; N J Petersen
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

4.  Two outbreaks of sternal wound infection due to organisms of the Mycobacterium fortuitum complex.

Authors:  P C Hoffman; D W Fraser; F Robicsek; P R O'Bar; C U Mauney
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

5.  Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.

Authors:  R J Wallace; J M Swenson; V A Silcox; M G Bullen
Journal:  J Infect Dis       Date:  1985-09       Impact factor: 5.226

6.  Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.

Authors:  R J Wallace; J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

7.  In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.

Authors:  N Khardori; H Nguyen; B Rosenbaum; K Rolston; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

Review 8.  Spectrum of disease due to rapidly growing mycobacteria.

Authors:  R J Wallace; J M Swenson; V A Silcox; R C Good; J A Tschen; M S Stone
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

9.  Identification of clinically significant Mycobacterium fortuitum complex isolates.

Authors:  V A Silcox; R C Good; M M Floyd
Journal:  J Clin Microbiol       Date:  1981-12       Impact factor: 5.948
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.